Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Operating Expenses | 6,865 | 7,609 | 8,872 | 5,521 | 6,953 |
Operating Income | -6,865 | -7,609 | -8,872 | -5,521 | -6,953 |
Interest Expense | 360 | 259 | 277 | 296 | 1,322 |
Other Income | -31 | -48 | -48 | 14 | -6 |
Pre-tax Income | -7,256 | -7,916 | -9,197 | -5,803 | -8,281 |
Net Income Continuous | -7,256 | -7,916 | -9,197 | -5,803 | -8,281 |
Net Income | $-7,256 | $-7,916 | $-9,197 | $-5,803 | $-8,281 |
EPS Basic Total Ops | -2.72 | -3.12 | -3.76 | -2.40 | -3.44 |
EPS Basic Continuous Ops | -2.70 | -3.15 | -3.71 | -2.42 | -3.48 |
EPS Diluted Total Ops | -2.72 | -3.12 | -3.76 | -2.40 | -3.44 |
EPS Diluted Continuous Ops | -2.70 | -3.15 | -3.71 | -2.42 | -3.48 |
EBITDA(a) | $-6,736 | $-7,478 | $-8,739 | $-5,387 | $-5,989 |